Autoantibodies, autoimmunity and cancer (review). 1998

Y Tomer, and Y Sherer, and Y Shoenfeld
Research Unit of Autoimmune Diseases and Department of Medicine, Sheba Medical Center, Tel-Hashomer and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

There is a strong association between neoplasms and autoimmune diseases. Numerous autoimmune phenomena have been reported in malignancies and conversely: malignant tumors are diagnosed in increasing frequency in autoimmune conditions. We review the most common autoimmune diseases and autoantibodies found in malignancies, discuss the therapeutic role of these autoantibodies in cancer, and summarize the current knowledge on malignant transformation in autoimmunity.

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000912 Antibodies, Neoplasm Immunoglobulins induced by antigens specific for tumors other than the normally occurring HISTOCOMPATIBILITY ANTIGENS. Neoplasm Antibodies,Tumor Antibodies,Antibodies, Tumor
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody
D001327 Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease,Disease, Autoimmune,Diseases, Autoimmune
D015551 Autoimmunity Process whereby the immune system reacts against the body's own tissues. Autoimmunity may produce or be caused by AUTOIMMUNE DISEASES. Autoimmune Response,Autoimmune Responses,Autoimmunities

Related Publications

Y Tomer, and Y Sherer, and Y Shoenfeld
July 2023, Endocrine-related cancer,
Y Tomer, and Y Sherer, and Y Shoenfeld
July 2003, Pathologie-biologie,
Y Tomer, and Y Sherer, and Y Shoenfeld
January 2015, Frontiers in immunology,
Y Tomer, and Y Sherer, and Y Shoenfeld
February 2006, The Journal of allergy and clinical immunology,
Y Tomer, and Y Sherer, and Y Shoenfeld
April 1997, Annals of the New York Academy of Sciences,
Y Tomer, and Y Sherer, and Y Shoenfeld
May 2023, Journal of autoimmunity,
Y Tomer, and Y Sherer, and Y Shoenfeld
November 2021, JAMA neurology,
Y Tomer, and Y Sherer, and Y Shoenfeld
July 1995, Clinical and experimental immunology,
Y Tomer, and Y Sherer, and Y Shoenfeld
July 2011, Nature reviews. Endocrinology,
Y Tomer, and Y Sherer, and Y Shoenfeld
January 1986, Acta haematologica,
Copied contents to your clipboard!